Biomarker-Based Clinical Trial Designs

December 9, 2010

Free Webinar on Biomarker-Based Clinical Trial Designs

  • The webinar on biomarker-based clinical trial designs reviewed of the recently proposed-designs, including adaptive designs, and discussed the main issues related to  their application. Their ability to validate the biomarker and/or to establish the effect of an experimental therapy in patient populations defined by the presence or absence of the biomarker is analyzed.
  • It focused on biomarkers that modify the prognosis of individual patients (“prognostic” biomarkers) and biomarkers that predict how individual patients will respond to specific treatments (“predictive” biomarkers, also called “effect modifiers”).  All discussed methods and concepts were  illustrated by using real-life examples from oncology.
  • Speakers:
    • Dr. Marc Buyse, ScD, Chairman, IDDI Consultants
    • Dr. Stefan Michiels, PhD, Breast Cancer Translational Research Unit, Institut Jules Bordet, and Senior Biostatistical Consultant, IDDI

 VIEW THE RECORDING OF THE WEBINAR HERE 

TO ACCESS THE PRESENTATION OF THIS ON-DEMAND WEBINAR, PLEASE FILL IN THE FORM BELOW

Presentation of the Webinar: Biomarker-Based Clinical Trial Designs

To access the presentation of this on-demand webinar, please fill in this form.

By submitting this form, you agree to receiving commercial electronic messages such as e-mails from IDDI. For more info, please visit our Privacy Policy. You can unsubscribe at any time by clicking the 'unsubscribe' button at the foot of any e-mail communication from IDDI.

I authorize IDDI to use my data to contact me for commercial purposes. More information
Powered by Atypic ®

IDDI